S&P 500
7,674.00
+0.27%
Dow Jones
53,264.00
+0.85%
Nasdaq 100
29,309.30
+0.23%
Russell 2000
3,016.29
+0.77%
FTSE 100
10,817.60
+0.67%
Nikkei 225
65,976.50
+0.73%

Investing

NVO logo Novo Nordisk : NVO

Price Target $136 ↑191.5%
›

NVO

Stock Data

$46.74

Change up

$0.60 (1.30%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - GENERAL

Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.

Latest Activity

Biggest movers · At the close
Gainers
  • PLTRPalantir$162.55+29.4%
  • AAOIApplied Optoelectronics$132.64+20.4%
  • ARMArm$280.61+17.4%
  • FNFabrinet$534.46+17.2%
  • COHRCoherent$330.85+14.8%
Losers
  • BRKRBruker$51.17-20.4%
  • VERXVertex$11.74-12.4%
  • CIFRCipher Mining$21.25-12.1%
  • AMCAMC Entertainment$2.63-7.7%
  • NVONovo Nordisk$44.09-6.4%

Palantir's 29% close pulled the entire AI complex with it, from Arm to the optical names supplying the data centers. Everything outside that trade got sold, with Bruker down 20% and Novo Nordisk sliding again.

Read more
NVONovo Nordisk
Regular session
$43.83
-7.96%open $47.62

An 8% slide to $43.83 leaves the obesity-drug pioneer worth just $147 billion, a fraction of the valuation it once commanded as GLP-1 competition and a shareholder suit over its next-generation weight-loss drug pile up. Keep an eye on how much lower the floor goes.

Read more

All Novo Nordisk Articles

179 Articles

1 2 3 … 12